The Abuse Characteristics of Amphetamine-Type Stimulants in Patients Receiving Methadone Maintenance Treatment and Buprenorphine Maintenance Treatment

References

• DowellD, AriasE, KochanekK, et al. Contribution of opioid-involved poisoning to the change in life expectancy in the United States 2000–2015. JAMA. 2017;318(11):1065–1067. doi:10.1001/jama.2017.930828975295
   PubMed Web of Science ®Google Scholar
• TsuiJI, BurtR, ThiedeH, et al. Utilization of buprenorphine and methadone among opioid users who inject drugs. Subst Abus. 2018;39(1):83–88. doi:10.1080/08897077.2017.136384428796591
   PubMed Web of Science ®Google Scholar
• MintzerMZ, StitzerML. Cognitive impairment in methadone maintenance patients. Drug Alcohol Depend. 2002;67(1):41–51. doi:10.1016/S0376-8716(02)00013-312062778
   PubMed Web of Science ®Google Scholar
• NosykB, FischerB, SunH, et al. High levels of opioid analgesic co-prescription among methadone maintenance treatment clients in British Columbia, Canada: results from a population-level retrospective cohort study. Am J Addict. 2014;23(3):257–264. doi:10.1111/j.1521-0391.2014.12091.x24724883
   PubMed Web of Science ®Google Scholar
• Kapitány-FövényM, FarkasJ, PatakiPA, et al. Novel psychoactive substance use among treatment-seeking opiate users: the role of life events and psychiatric symptoms. Hum Psychopharmacol. 2017;32(3):e2602. doi:10.1002/hup.2602
   Web of Science ®Google Scholar
• YinW, HaoY, SunX, et al. Scaling up the national methadone maintenance treatment program in China: achievements and challenges. Int J Epidemiol. 2010;39(Suppl 2):ii29–ii37. doi:10.1093/ije/dyq21021113034
   PubMed Web of Science ®Google Scholar
• SchottenfeldRS, ChawarskiMC, MazlanM. Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomized, double-blind, placebo-controlled trial. Lancet. 2008;371(9631):2192–2200.18586174
   PubMed Web of Science ®Google Scholar
• MilwardJ, LynskeyM, StrangJ. Solving the problem of non-attendance in substance abuse services. Drug and Alcohol Rev. 2014;33(6):625–636. doi:10.1111/dar.1219425196817
   PubMed Web of Science ®Google Scholar
• HserYI, LiJ, JiangH, et al. Effects of a randomized contingency management intervention on opiate abstinence and retention in methadone maintenance treatment in China. Addiction. 2011;106(10):1801–1809. doi:10.1111/j.1360-0443.2011.03490.x21793958
   PubMed Web of Science ®Google Scholar
• UmbrichtA, DefulioA, WinstanleyEL, et al. Topiramate for cocaine dependence during methadone maintenance treatment: a randomized controlled Trial. Drug Alcohol Depend. 2014;140:92–100. doi:10.1016/j.drugalcdep.2014.03.03324814607
   PubMed Web of Science ®Google Scholar
• United Nations Office on Drugs and Crime. World Drug Report Volume 1. Analysis. Vienna: United Nations Office on Drugs and Crime; 2007.
   Google Scholar
• KoesterP, TittgemeyerM, WagnerD, BeckerB, Gouzoulis-MayfrankE, DaumannJ. Cortical thinning in amphetamine-type stimulant users. Neuroscience. 2012;221:182–192. doi:10.1016/j.neuroscience.2012.06.04922750208
   PubMed Web of Science ®Google Scholar
• VigezziP, GuglieminoL, MarzoratiP. Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin-and cocaine -dependent patients. J Subst Abuse Treat. 2006;31(1):3–7. doi:10.1016/j.jsat.2006.03.00716814005
   PubMed Web of Science ®Google Scholar
• DeMariaPA Jr, SterlingR, WeinsteinSP. The effect of stimulant and sedative use on treatment outcome of patients admitted to methadone maintenance treatment. Am J Addict. 2000;9(2):145–153. doi:10.1080/1055049005017321710934576
   PubMed Web of Science ®Google Scholar
• JianhuaL, XinyueL. Current status of drug use and HIV/AIDS prevention in drug users in China. J Food Drug Anal. 2013;21(4):S37–41. doi:10.1016/j.jfda.2013.09.03125284965
   PubMed Web of Science ®Google Scholar
• OrnsteinTJ, IddonJL, BaldacchinoAM, et al. Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers. Neuropsychopharmacology. 2000;23(2):113–126. doi:10.1016/S0893-133X(00)00097-X10882838
   PubMed Web of Science ®Google Scholar
• ChengZ, ChenGH, DaiMM, et al. New psychoactive substances abuse among patients with access to methadone maintenance treatment in jiangsu province: a case-control Study. Chin J Epidemiol. 2018;39(5):625–630.
   Google Scholar
• LiJH, LiXY. Current status of drug use and HIV/AIDS prevention in drug users in China. J Food Drug Anal. 2013;21(4):S37–S41.25284965
   PubMed Web of Science ®Google Scholar
• BelinD, MarAC, DalleyJW, et al. High impulsivity predicts the switch to compulsive cocaine taking. Science. 2008;320(5881):1352–1355. doi:10.1126/science.115813618535246
   PubMed Web of Science ®Google Scholar
• KathrynA, AnastasiaCN. Serotonin at the Nexus of impulsive and cue reactivity in cocaine addiction. Neuropharmacology. 2014;76(0):460–478. PMID: 23850573.23850573
   PubMed Web of Science ®Google Scholar
• NiggJT, WongMM, MartelMM, et al. Poor response inhibition as a predictor of problem drinking and illicit drug use in adolescents at risk for alcoholism and other substance use disorders. J Am Acad Child Adolesc Psychiatry. 2006;45(4):468–475. [ PMID:16601652]. doi:10.1097/01.chi.0000199028.76452.a916601652
   PubMed Web of Science ®Google Scholar
• PerryJL, CarrollME. The role of impulsive behavior in drug abuse. Psychopharmacology. 2008;200(1):1–26.18600315
   PubMed Web of Science ®Google Scholar
• ReynoldsB. A review of delay-discounting research with humans: relations to drug use and gambling. Behav Pharmacol. 2006;17(8):651–667. doi:10.1097/FBP.0b013e3280115f9917110792
   PubMed Web of Science ®Google Scholar
• BickelWK, JarmolowiczDP, MuellerET, et al. Excessive discounting of delayed reinforcers as a trans-disease process contributing to addiction and other disease-related vulnerabilities: emerging evidence. Pharmacol Ther. 2012;134(3):287–297. doi:10.1016/j.pharmthera.2012.02.00422387232
   PubMed Web of Science ®Google Scholar
• YaghubiM, ZargarF, AkbariH. Comparing effectiveness of mindfulness-based relapse prevention with treatment as usual on impulsivity and relapse for methadone-treated patients: a randomized clinical Trial. Addict Health. 2017;9(3):156–165.29657696
   PubMedGoogle Scholar
• Fernández-SerranoMJ, PeralesJC, Moreno-LópezL, et al. Neuropsychological profiling of impulsivity and compulsivity in cocaine dependent individuals. Psychopharmacology. 2012;219(2):673–683. doi:10.1007/s00213-011-2485-z21922168
   PubMed Web of Science ®Google Scholar
• StevensL, RoeyersH, DomG, et al. Impulsivity in cocaine-dependent individuals with and without attention-deficit/hyperactivity disorder. Eur Addict Res. 2015;21(3):131–143. doi:10.1159/00036900825675959
   PubMed Web of Science ®Google Scholar
• MoellerFG, BarrattES, DoughertyDM, et al. Psychiatric aspects of impulsivity. Am J Psychiatry. 2001;158(11):1783–1793. doi:10.1176/appi.ajp.158.11.178311691682
   PubMed Web of Science ®Google Scholar
• MoellerFG, DoughertyDM, BarrattES, et al. The impact of impulsivity on cocaine use and retention in treatment. J Subst Abuse Treat. 2001;21(4):193–198. doi:10.1016/S0740-5472(01)00202-111777668
   PubMed Web of Science ®Google Scholar
• McLellanAT, LuborskyL, CacciolaJ, et al. New data from the Addiction Severity Index: reliability and validity in three cen-ters. J Nerv Ment Dis. 1985;173(7):412–423. doi:10.1097/00005053-198507000-000054009158
   PubMed Web of Science ®Google Scholar
• LiangT, LiuEW, ZhongH. Reliability and validity of addiction severity index(ASI) Chinese version in evaluation of heroin addiction methadone maintenance treatment. Chin J Drug Depend. 2007;16(6):451–458.
   Google Scholar
• PattonJH, StanfordMS, BarrattES. Factor structure of the barratt impulsiveness scale. J Clin Psychol. 1995;51(6):768–774. doi:10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-18778124
   PubMed Web of Science ®Google Scholar
• ZhouL, XiaoSY, HeXY. Reliability and validity of chinese version of barratt impulsiveness scale-11. Chin J Clin Psychol. 2006;14(4):343–344.
   Google Scholar
• HadenSC, ShivaA. Trait impulsivity in a forensic inpatient sample: an evaluation of the Barratt impulsiveness scale. Behav Sci Law. 2008;26(6):675–690. doi:10.1002/bsl.82019039789
   PubMed Web of Science ®Google Scholar
• BishopB, GilmourJ, DeeringD. Readiness and Recovery: transferring between methadone and buprenorphine/naloxone for the treatment of opioid use disorder. Int J Ment Health Nurs. 2019;28(1):226–236. doi:10.1111/inm.1252330019812
   PubMed Web of Science ®Google Scholar
• KahanM, SrivastavaA, OrdeanA. Buprenorphine: new treatment of opioid addiction in primary care. Can Fam Physician. 2011;57(3):281–289.21402963
   PubMed Web of Science ®Google Scholar
• SrivastavaA, KahanM, NaderM. Primary care management of opioid use disorders: abstinence, methadone, or buprenorphine-naloxon? Can Fam Physician. 2017;63(3):200–205.28292795
   PubMed Web of Science ®Google Scholar
• DalleyJW, EverittBJ, RobbinsTW. Impulsivity, compulsivity, and top-down cognitive control. Neuron. 2011;69(4):680–694. doi:10.1016/j.neuron.2011.01.02021338879
   PubMed Web of Science ®Google Scholar
• EvendenJL. Varieties of impulsivity. Psychopharmacology. 1999;146(4):348–361. doi:10.1007/PL0000548110550486
   PubMed Web of Science ®Google Scholar
• RossEL, YoonJH, MahoneyJJ, et al. The impact of self-reported life stress on current impulsivity in cocaine dependent adults. Prog Neuropsychopharmacol Biol Psychiatry. 2013;46:113–119. doi:10.1016/j.pnpbp.2013.06.00223796525
   PubMed Web of Science ®Google Scholar
• PikeE, MarksKR, StoopsWW, et al. Cocaine -related stimuli Impair inhibitory control in cocaine users following short stimulus onset asynchronies. Addiction. 2015;110(8):1281–1286. doi:10.1111/add.1294725873430
   PubMed Web of Science ®Google Scholar
• NielsenDA, HoA, BahlA, et al. Former heroin addicts with or without a history of cocaine dependence are more impulsive than controls. Drug Alcohol Depend. 2012;124(1–2):113–120. doi:10.1016/j.drugalcdep.2011.12.02222265192
   PubMed Web of Science ®Google Scholar
• JiaZ-J, YanS-Y, BaoY-P, LianZ, ZhangH-R, LiuZ-M. Sexual behavior differences between amphetamine-type stimulants users and heroin users. J Addict Med. 2013;7(6):422–427. doi:10.1097/ADM.0b013e3182a952b224145161
   PubMed Web of Science ®Google Scholar
• WangR, DingY, BaiH, et al. Illicit heroin and methamphetamine use among methadone maintenance treatment patients in Dehong Prefecture of Yunnan Province, China. PLoS One. 2015;10(7):e0133431. doi:10.1371/journal.pone.013343126196394
   PubMed Web of Science ®Google Scholar
• DuJ, SunH, HuangD, et al. Use trajectories of Amphetamine–type stimulants(ATS) in Shanghhai, China. Drug Alcohol Depend. 2014;143:44–50. doi:10.1016/j.drugalcdep.2014.06.03125081602
   PubMed Web of Science ®Google Scholar
• ChengZ, DaiMM, CaoXB. [Current situation on new psychoactive substances abuse among methadone maintenance treatment patients in China]. Zhonghua Liu Xing Bing Xue Za Zhi. 2018;39(4):536–540. [ Chinese]. doi:10.3760/cma.j.issn.0254-6450.2018.01.03029699053
   PubMedGoogle Scholar